Pediatrix Medical Group, Inc. - 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2000. Pediatrix Medical Group, Inc. operates as a physician group practice providing neonatal and pediatric services. The company continues to expand through acquisitions and organic growth while managing ongoing legal and regulatory inquiries regarding billing practices.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2000 | Nine Months Ended Sep 30, 2000 |
|---|---|---|
| Net Patient Service Revenue | $64.3 million | $178.9 million |
| Net Income | $3.8 million | $6.9 million |
| Diluted EPS | $0.24 | $0.43 |
| Operating Income | $8.4 million | $16.2 million |
| Cash and Equivalents | $1.9 million | $1.9 million (Balance Sheet) |
| Operating Cash Flow (9mo) | $21.3 million | |
| Debt (Line of Credit) | $38.8 million outstanding of $75 million facility | |
| Working Capital | Deficit of $8.7 million (due to current classification of line of credit) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 11.0% for the quarter and 6.1% for the nine-month period compared to 1999. However, the nine-month revenue figure includes a $6.5 million charge recorded in Q2 2000 to increase the allowance for contractual adjustments and uncollectible accounts.
- Profitability Decline: Net income decreased 23.2% for the quarter and 65.5% for the nine-month period year-over-year. Operating income dropped 54.0% for the nine-month period, largely driven by the $6.5 million revenue charge and increased operating expenses.
- Expense Increases: Salaries and benefits rose 21.9% for the nine months, driven by hiring new physicians for acquisitions and increased support staff. Supplies and other operating expenses increased 26.2% due to rent, legal fees related to investigations, and new outpatient offices.
- Acquisitions: The company acquired four physician group practices in the first nine months of 2000 for approximately $8.4 million in cash.
Outlook, Risks, and Contingencies
- Liquidity: The company refinanced its $75 million line of credit, which matures on September 30, 2001. With $36.2 million available, management believes cash flow and credit facilities are sufficient for the next 12 months.
- Legal Proceedings: A consolidated federal securities class action lawsuit remains pending regarding accounting practices and revenue recognition. Discovery is ongoing, with a pre-trial conference scheduled for May 2001. The company intends to vigorously defend the claims.
- Regulatory Settlements: The company settled billing inquiries with Florida ($40,000) and Arizona ($220,000) in 2000. Both settlements stated no fraud was committed, attributing overpayments to billing code clarity. An inquiry in Colorado remains ongoing.
- Tax Rate: The effective income tax rate increased to 48.8% for the nine-month period due to non-deductible goodwill and lower estimated pretax income.
Investor Verification Checklist
- Verify the impact of the $6.5 million reserve charge on future revenue recognition and the adequacy of the allowance for uncollectible accounts.
- Monitor the status of the Colorado billing investigation and potential financial exposure, as the outcome is currently unpredictable.
- Assess the sustainability of operating margins given the 21.9% increase in salary expenses relative to revenue growth.
- Review the working capital deficit of $8.7 million and the reliance on the $75 million line of credit for liquidity.
- Track the progress of the federal securities class action lawsuit and any potential settlement costs or judgments.